Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: Heterogeneous expression of EBI3 subunit by tumoral cells

American Journal of Pathology

Volumn 166, Issue 4, 2005, Pages 1217-1228

  Larousserie, Frédérique ^a,b   Bardel, Emilie ^a   Pflanz, Stefan ^d,f   Arnulf, Bertrand ^c   Lome Maldonado, Carmen ^e   Hermine, Olivier ^a   Brégeaud, Laurence ^b   Perennec, Monique ^b   Brousse, Nicole ^b   Kastelein, Rob ^d   Devergne, Odile ^a,b  

^a CNRS   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d MERCK RESEARCH LABORATORIES   (United States)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^f MICROMET AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 27; ONCOPROTEIN; PROTEIN P28;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CARCINOGENESIS; CELL LINE; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1 ASSOCIATED LYMPHOMA; IMMUNE RESPONSE; LEUKEMIA CELL LINE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION;

EID: 20244390313     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62340-1     Document Type: Article

References (41)

1. Rickinson A, Kieff E: Epstein-Barr virus. Fields Virology, 4th ed. Edited by Knipe DM, Howley PM. Philadelphia, Lippincott/Williams & Wilkins Co., 2001, pp 2575-2628
2. Küppers R: B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 2003, 3:801-812
3. Yoshida M: Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001, 19:475-496
4. Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, Birkenbach M: A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 1996, 70:1143-1153
5. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, Blumenschein WM, Mattson JD, Wagner JL, To W, Zurawski S, McClanahan TK, Gorman DM, Bazan JF, de Waal Malefyt R, Rennick D, Kastelein RA: IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790
6. Pflanz S, Hibbert L, Mattson J, Resales R, Vaisberg E, Bazan JF, Phillips JH, McClanahan TK, de Waal Malefyt R, Kastelein RA: WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004, 172:2225-2231
7. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, Yoshimura A, Yoshida H: Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 2003, 170:4886-4890
8. Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA: IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 2003, 23:513-522
9. Lucas S, Ghilardi N, Li J, de Sauvage FJ: IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci USA 2003, 100:15047-15052
10. Chen Q, Ghilardi N, Wang H, Baker T, Xie MH, Gurney A, Grewal IS, de Sauvage FJ: Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000, 407:916-920
11. Yoshida H, Hamano S, Senaldi G, Covey T, Faggioni R, Mu S, Xia M, Wakeham AC, Nishina H, Potter J, Saris CJ, Mak TW: WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001, 15:569-578
12. Larousserie F, Pflanz S, Coulomb-L'Herminé A, Brousse N, Kastelein R, Devergne O: Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol 2004, 202:164-171
13. Trinchieri G, Pflanz S, Kastelein RA: The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003, 19:641-644
14. Hamano S, Himeno K, Miyazaki Y, Ishii K, Yamanaka A, Takeda A, Zhang M, Hisaeda H, Mak TW, Yoshimura A, Yoshida H: WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 2003, 19:657-667
15. Villarino A, Hibbert L, Lieberman L, Wilson E, Mak T, Yoshida H, Kastelein RA, Saris C, Hunter CA: The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 2003, 19:645-655
16. Devergne O, Cahir McFarland ED, Mosialos G, Izumi KM, Ware CF, Kieff E: Role of the TRAF binding site and NF-κB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J Virol 1998, 72:7900-7908
17. Cahir McFarland ED, Izumi KM, Mosialos G: Epstein-Barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-κB. Oncogene 1999, 18:6959-6964
18. Niedobitek G, Pazolt D, Teichmann M, Devergne O: Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J Pathol 2002, 198:310-316
19. Hiscott J, Kwon H, Genin P: Hostile takeovers: viral appropriation of the NF-κB pathway. J Clin Invest 2001, 107:143-151
20. Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, Yamamoto N: Constitutive activation of NF-κB in primary adult-T-cell leukemia cells. Blood 1999, 93:2360-2368
21. Arima N, Matsushita K, Obata H, Ohtsubo H, Fujiwara H, Arimura K, Kukita T, Suruga Y, Wakamatsu S, Wakamastu S, Hidaka S, Tei C: NF-κB involvement in the activation of primary adult-T-cell leukemia cells and its clinical implications. Exp Hematol 1999, 27:1168-1175
22. Shimoyama M: Diagnostic criteria and classification of clinical sub-types of adult T-cell leukaemia-lymphoma. Br J Haematol 1991, 79:428-437
23. Devergne O, Coulomb-L'Herminé A, Capel F, Moussa M, Capron F: Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol 2001, 159:1763-1776
24. Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E: Role of NF-κB in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J Virol 2004, 78:4108-4119
25. Li J, Peet GW, Balzarano D, Li X, Massa P, Barton RW, Marcu KB: Novel NEMO/lκB kinase and NK-κB target genes at the pre-B to immature B cell transition. J Biol Chem 2001, 276:18579-18590
26. Dadgostar H, Zarnegar B, Hoffmann A, Qin XF, Truong U, Rao G, Baltimore D, Cheng G: Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes. Proc Natl Acad Sci USA 2002, 99:1497-1502
27. Smith MR, Greene WC: Identification of HTLV-1 tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev 1990, 4:1875-1885
28. Mori N, Yamada Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N, Fujii M: Bay 11-7082 inhibits transcription factor NF-κB and induces apoptosis of HTLV-1-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002, 100:1828-1834
29. Nagai T, Devergne O, Mueller TF, Perkins DL, van Seventer JM, van Seventer GA: Timing of IFN-β exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-β-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J Immunol 2003, 171:5233-5243
30. Staudt LM: The molecular and cellular origins of Hodgkin's disease. J Exp Med 2000, 191:207-212
31. Skinnider BF, Mak TW: The role of cytokines in classical Hodgkin lymphoma. Blood 2002, 99:4283-4297
32. Setoyama M, Fujiyoshi T, Mizoguchi S, Katahira Y, Yashiki S, Tara M, Kanzaki T, Sonoda S: HTLV-1 messenger RNA is expressed in vivo in adult-T-cell leukemia/lymphoma patients: an in situ hybridization study. Int J Cancer 1994, 57:760-764
33. Ohshima K, Suzumiya J, Izumo S, Mukai Y, Tashiro K, Kikuchi M: Detection of human T-lymphotropic virus type-I DNA and mRNA in the lymph nodes using polymerase chain reaction in situ hybridization (PCR/ISH) and reverse transcription (RT-PCR/ISH). Int J Cancer 1996, 66:18-23
34. Horie R, Watanabe M, Ishida T, Koiwa T, Aizawa S, Itoh K, Higashihara M, Kadin ME, Watanabe T: The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-κB activation in anaplastic large cell lymphoma. Cancer Cell 2004, 5:353-364
35. Izban KF, Ergin M, Qin JZ, Martinez RL, Pooley Jr RJ, Saeed S, Alkan S: Constitutive expression of NF-κB is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis. Hum Pathol 2000, 12:1482-1490
36. Mosialos G: Cytokine signaling and Epstein-Barr virus-mediated cell transformation. Cytokine Growth Factor Rev 2001, 12:259-270
37. Matsuoka M: Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 2003, 22:5131-5140
38. Hisada M, Kamiya S, Fujita K, Belladonna ML, Aoki T, Koyanagi Y, Mizuguchi J, Yoshimoto T: Potent antitumor activity of interleukin-27. Cancer Res 2004, 64:1152-1156
39. Devergne O, Birkenbach M, Kieff E: Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA 1997, 94:12041-12046
40. Nieuwenhuis EE, Neurath MF, Corazza N, Iijima H, Trgovcich J, Wirtz S, Glickman J, Bailey D, Yoshida M, Galle PR, Kronenberg M, Birkenbach M, Blumberg RS: Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci USA 2002, 99:16951-16956
41. Matsui M, Moriya O, Belladonna ML, Kamiya S, Lemonnier FA, Yoshimoto T, Akatsuka T: Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. J Virol 2004, 78:9093-9104.